Trevi Therapeutics, Inc. (TRVI)

Trevi Therapeutics Statistics

Total Valuation

TRVI has a market cap or net worth of $1.44 billion. The enterprise value is $1.25 billion.

Market Cap	1.44B
Enterprise Value	1.25B

Important Dates

The last earnings date was Tuesday, March 17, 2026, after market close.

Earnings Date	Mar 17, 2026
Ex-Dividend Date	n/a

Share Statistics

TRVI has 128.40 million shares outstanding. The number of shares has increased by 32.14% in one year.

Current Share Class	128.40M
Shares Outstanding	128.40M
Shares Change (YoY)	+32.14%
Shares Change (QoQ)	+0.27%
Owned by Insiders (%)	0.77%
Owned by Institutions (%)	84.13%
Float	103.93M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	7.84
P/TBV Ratio	7.84
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 19.66, with a Debt / Equity ratio of 0.00.

Current Ratio	19.66
Quick Ratio	19.41
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -30.23% and return on invested capital (ROIC) is -21.66%.

Return on Equity (ROE)	-30.23%
Return on Assets (ROA)	-20.26%
Return on Invested Capital (ROIC)	-21.66%
Return on Capital Employed (ROCE)	-26.85%
Weighted Average Cost of Capital (WACC)	9.69%
Revenue Per Employee	n/a
Profits Per Employee	-$1.26M
Employee Count	34
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-64,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +72.15% in the last 52 weeks. The beta is 0.99, so TRVI's price volatility has been similar to the market average.

Beta (5Y)	0.99
52-Week Price Change	+72.15%
50-Day Moving Average	11.16
200-Day Moving Average	9.81
Relative Strength Index (RSI)	48.55
Average Volume (20 Days)	1,384,095

Short Selling Information

The latest short interest is 16.44 million, so 12.81% of the outstanding shares have been sold short.

Short Interest	16.44M
Short Previous Month	16.81M
Short % of Shares Out	12.81%
Short % of Float	15.82%
Short Ratio (days to cover)	12.94

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-49.33M
Pretax Income	-42.82M
Net Income	-42.76M
EBITDA	-49.18M
EBIT	-49.33M
Earnings Per Share (EPS)	-$0.32

Balance Sheet

The company has $188.26 million in cash and $753,000 in debt, with a net cash position of $187.51 million or $1.46 per share.

Cash & Cash Equivalents	188.26M
Total Debt	753,000
Net Cash	187.51M
Net Cash Per Share	$1.46
Equity (Book Value)	183.24M
Book Value Per Share	1.43
Working Capital	181.91M

Cash Flow

In the last 12 months, operating cash flow was -$42.09 million and capital expenditures -$12,000, giving a free cash flow of -$42.10 million.

Operating Cash Flow	-42.09M
Capital Expenditures	-12,000
Depreciation & Amortization	144,000
Net Borrowing	-11,000
Free Cash Flow	-42.10M
FCF Per Share	-$0.33

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TRVI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-32.14%
Shareholder Yield	-32.14%
Earnings Yield	-2.98%
FCF Yield	-2.93%

Analyst Forecast

The average price target for TRVI is $21.55, which is 92.58% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$21.55
Price Target Difference	92.58%
Analyst Consensus	Strong Buy
Analyst Count	11
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2